Diagnostics

Fractal's new healthcare AI has surpassed leading models from OpenAI and Google, signaling a major leap for India's sovereign AI ambitions and public health.

At a major scientific conference, Seer Inc.'s Proteograph platform is taking center stage, promising deeper insights into Alzheimer's and heart disease.

A new blood test can predict when Alzheimer's symptoms will start, years in advance. This breakthrough could revolutionize research, but raises deep ethical questions.

A landmark deal will deploy advanced Belgian particle accelerators across India, aiming to revolutionize cancer diagnostics and patient access in a booming market.

Seer, Inc. heads to the TD Cowen conference, putting its innovative proteomics technology and market strategy under the investor microscope.

With COVID revenue fading, QuidelOrtho will use a key conference to prove its diversified diagnostics model can deliver on growth, margins, and cash flow.

A new, affordable sonography degree in Southwest Kansas aims to fill critical healthcare jobs and keep local talent at home through a unique partnership.

A groundbreaking, NIH-funded trial will use advanced PET imaging to test new Alzheimer's drugs, with XingImaging managing the critical visual data.

Flatiron Health launches a first-of-its-kind AI platform, merging data from 400,000 patients to revolutionize prostate cancer research and treatment.

With a new veteran chairman and validated at-home testing, Fellow Health is poised to disrupt the male fertility market. Here's what the move means.

Photocure reports robust Q4 earnings and a strong 2026 forecast, while pivoting to an AI-driven future for bladder cancer diagnostics and global expansion.

A groundbreaking collaboration is turning discarded biopsy material into a powerful tool for AI-driven cancer diagnostics, promising a new era of proactive care.

With over 2 million visitors at Expo 2025, Thailand showcased breakthrough medical tech. But can it translate this success into a global healthcare powerhouse?

As dental practices face critical labor shortages, a new wave of AI-powered platforms like Jobley aims to revolutionize hiring. But is it the cure?

Pioneering surgeon Dr. Gopal H. Badlani receives a top honor for his decades of work building sustainable urological care in underserved nations.

A new study shows an AI-powered device can identify infants at high risk for atopic dermatitis at birth, paving the way for proactive, preventative care.

Copan's PhenoMATRIX® gains FDA 510(k) clearance, unleashing AI to speed up bacterial analysis and reshape the future of clinical diagnostics in America.

Integrity College of Health's maximum six-year reaccreditation offers a key validation for parent company Legacy Education amid a shifting regulatory climate.

A major update to the Kosmos platform brings cart-grade OB/GYN and vascular tools to a portable device, reshaping diagnostics from the ER to rural clinics.

In a landmark $9.9 billion all-cash deal, Danaher will acquire Masimo, aiming to dominate the patient monitoring market from hospital to home.